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Epidemiology of Congenital
Diaphragmatic Hernia,
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Mathias B. Forrester BS* and Ruth D. Merz MS**
Congenital diaphragmatic hernias (CDHs) in Hawaii between 1987
and 1996 were examined with data from a birth defects surveillance
system. There were 51 cases of CDH (prevalence 2.45 per 10,000
births). Forty-nine percent of livebirths survivec an increase over
the rate reported in Hawaii in 1975- 1982. These results are similar
to those reported by other population-based studies.
Introduction
Congenital diaphragmatic hernia (CDH), a birth defect in which
an incompletely developed diaphragm allows the abdominal organs
to herniate into the chest, occurs in approximately 3-4 per 10,000
births.1-3Although the defect can be repaired surgically, the mortal
ity rate from CDH is still high.’-5 One study has estimated that the
treatment and care of each individual with CDH would cost approxi
mately $250,000 in direct and indirect costs over his or her lifetime.6
Little is known about the etiology of CDH. Epidemiologic studies
have noted an association between CDH and chromosomal abnor
malities, and that a high proportion of CDH cases also have other
structural defects)-357One study reported anon-significant increase
in CDH prevalence over time, and greater prevalence of the defect
among males, but no differences by ethnic group, maternal age, or
parity.2
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CDH can be detected in-utero by ultrasonography,8and the
detection of serious birth defects in pregnancy has led to the elective
termination of affected pregnancies.2’357 A number of the birth
defect surveillance systems currently in operation were createdprior
to the common use ofprenatal screens and diagnostic tests. Many of
these systems do not include in their ascertainment elective preg
nancy terminations following the prenatal diagnosis ofbirth defects.
As a consequence, most of these systems cannot evaluate the impact
ofprenatal diagnosis and elective termination on CDH rates. Several
studies have reported from ito 21 percent of prenatally diagnosed
and 1 to 5 percent of all CDH pregnancies are electively termi
nated.2’37
In this study, data collected by the Hawaii Birth Defects Program
(HBDP) was used to examine the CDH mortality rate over a 10-year
period (1987-1996) in Hawaii. It investigates the effect of demo
graphic factors such as maternal ethnicity and age on the prevalence
of the defect and the proportion of cases with chromosomal and
other structural defects. The study also evaluates the impact of
prenatal diagnosis and elective termination on the prevalence of
CDH. Because the HBDP has nearly universal access to prenatal
diagnostic information and follow-up data on elective terminations,
Hawaii is an ideal setting in which to study their effects on the
prevalence rates of birth defects.
Methods
Data were from the Hawaii Birth Defects Program (HBDP), a
population-based, active surveillance system for birth defects and
other adverse reproductive/pregnancy outcomes for the entire state
of Hawaii. All pregnancies are included in the HBDP regardless of
outcome (livebirth, fetal demise, or elective termination) or the
gestational age of the fetus at the end of the pregnancy. In order to
be included in the registry: 1) the pregnancy must be affected by one
or more moderate to severe birth defects or other adverse conditions
such as antenatal maternal substance abuse, neoplasms, and con
genital infections; 2) the end of the pregnancy must occur in Hawaii;
and 3) the diagnosis must be made prenatally or within one year after
delivery.
Affected pregnancies were identified by examining lists ofmedi
cal record diagnostic codes and other reports provided by hospitals
where births and terminations due to fetal anomalies occur, tertiary
care facilities, and clinics and laboratories that perform prenatal
diagnostic screening, testing, or follow-up counseling. In addition to
clinical information about each reported infant or fetus, the HBDP
collected data on demographic characteristics, health behaviors, and
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other medical information regarding the biological parents.
The analysis included ten years of data collected from 1987
through 1996 on all reported cases with congenital absence or hernia
of the diaphragm. Cases with a probable orpossible diagnosis which
could not be confirmed were excluded from the analysis, as were
cases ofeventration of the diaphragm. The pregnancy outcome, year
of birth, place of residence, sex, plurality, side of defect, and
maternal age and race/ethnicity for each case were determined.
Ethnicity was grouped as white, Far East Asian (Japanese, Chinese,
and Korean), Pacific Islander, and Filipino. Cases belonging to other
races/ethnicities (black, Hispanic, etc.) were excluded from the
race/ethnicity analysis because of their relatively small numbers in
Hawaii’s birth population. The presence of chromosomal and/or
other major structural anomalies were identified. Diagnoses of
hypoplastic lung, malrotation, and defects associated with prematu
rity (patent ductus arteriosus, patent foramen ovale) were excluded
in the analysis of additional anomalies.
The various demographic factors were examined and compared
with livebirth and stillbirth data provided by the Hawaii State
Department of Health/Office of Health Status Monitoring, as de
rived from birth and fetal death certificates. Prenatal diagnosis,
elective termination, and survival rates were calculated. Ninety-five
percent confidence intervals were calculatedby Poissonprobability.
Secular trends were analyzed by the Chi-square tests for trend.
Results
The study identified 51 confirmed cases of congenital diaphrag
matic hernia (CDH) in Hawaii between 1987 and 1996 for a
prevalence of 2.45 per 10,000 births (95 percent confidence interval
(CI) 1.82-3.22). All were the posterolateral type of diaphragmatic
hernia except for one case ofMorgagni diaphragmatic hernia. Of the
31 cases where the side of the defect was known, 26 (83.9 percent)
were on the left and 5 (16.1 percent) on the right. Thirty (58.8
percent) of the cases were isolated while 21(41.2 percent) had one
or more other congenital anomalies not typically associated with
CDH. Five of the cases, all of which had other congenital anomalies,
were found to have chromosomal abnormalities (3 trisomy 18, 1
thsomy 16, 1 4-p-). This represents 9.8 percent of all CDH cases or
22.7 percent of those cases which were known to have had cytoge
netic tests performed. Three (5.9 percent) ofthe CDH cases occurred
among multiple births (2 sets of discordant twins and 1 set of
discordant triplets).
The prevalence ofCDH for each year is presented in table 1. There
was a slight decline in the CDH prevalence over the ten-year period
of study but this trend was not statistically significant (P=0.173).
Twelve (23.5 percent) of the cases were prenatally diagnosed.
When the proportional prenatally diagnosed were examined for
secular trends (table 1), a general increase over time was observed
but not statistically significant (P=0.268).
Forty-five (88.2) of the CDH cases were liveborn while 1 (2.0
percent) was a fetal demise and 5(9.8 percent of total or 41.7 percent
of prenatally diagnosed cases) were electively terminated. Of the
electively terminated cases, 2 were isolated cases of CDH while 3
had other congenital anomalies of which 2 included chromosomal
abnormalities. There was nevermore than one electively terminated
case in any given year and these cases were evenly distributed
throughout the ten-year period of study.
Of the 45 livebom CDH cases, 22 were known to be alive at one
year ofage, giving a survival rate of48.9 percent. None of the 7 cases
which had been prenatally diagnosed and not electively terminated
survived to one year, while 57.9 percent of the cases not prenatally
diagnosed survived. Fifteen (53.6 percent) ofthe livebom cases with
isolated CDH survived, while only 7 (41.2 percent) of those with
other congenital abnormalities survived. Table 1 presents the total
one-year survival rate for liveborns with CDH by year of diagnosis.
The survival rate varied between 25.0 and 100.0 percent during the
ten-year period of study. A slight decrease in survival rate was
detected; however, this decline was not statistically significant
(P=0.771).
The prevalence of CDH by various demographic factors is exhib
ited in table 2. Whites had the highest prevalence among racial/
ethnic groups, followed by Filipinos, Far East Asians, and Pacific
islanders. Maui and Kauai Counties were found to have similar
prevalence of CDH while the prevalence in the City and County of
Honolulu was somewhat lower . The prevalence in Hawaii County
was less than one-fifth that ofthe other counties. The prevalence was
similar between metropolitan Honolulu and the rest of the state. The
prevalence among mothers less than age twenty years was highest,
almost double the next highest prevalence (3 5-39 years age group).
None of the differences observed for any of the demographic factors
was statistically significant.
Discussion
The prevalence of CDH in Hawaii between 1987 and 1996 was
calculated to be 2.45 per 10,000 births. This is lower than the
prevalence reported in other states: Iowa (2.7), California (3.3), and
Utah (3.9).13 Only the Iowa study’ did not include elective termina
tions in its analysis, so differences in pregnancy outcomes cannot
account for the prevalence differences between the studies.
Since this study identified a slight decline, albeit not statistically
significant, in the prevalence over the ten-year period of study, and
several of the other studies covered time periods preceding that of
the current study,’2it could be suggested that the CDH prevalence
in Hawaii was higher in the past and thus similar to that observed in
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Table 1.—Prenatal diagnosis, pregnancy outcome, and survival rate (for
at least one year) of congenital diaphragmatic hernia by year, Hawaii,
1987-1996.
Year Total Prenatally Elecive Survival
rate diagnosed terminations rate
No. No. %
1987 1.99 1 0 25
1988 2.92 0 0 67
1989 4.77 2 1 44
1990 2.69 1 1 80
1991 2.30 1 0 60
1992 2.33 2 1 25
1993 2.37 2 0 25
1994 0.96 1 1 100
1995 2.53 2 1 25
1996 1.55 0 0 67
Total 2.45 12 5 49
‘per 10,000 births
the other studies. However, if the current analysis is restricted to
livebirths, the prevalence of 2.32 per 10,000 births is greater than
that of 1.9 per 10,000 livebirths reported in Hawaii in 1975-1982,
a time prior to the creation of the HBDP. Moreover, the Utah study3
covered a time period similar to the present one. So secular trends
cannot explain the prevalence differences.
For those cases where the side of the defect was known, the vast
majority (84 percent) were on the left side, a finding consistent with
that of other studies, 1.2.5,7 where the proportion of CDH which were
on the left ranged from 78 percent to 92 percent. Approximately ten
percent of all CDH cases (23 percent of those undergoing cytoge
netic analysis) were found to have a chromosomal abnormality. This
proportion is slightly higher than that seen in other studies,’-3but
only one-third that found in another study.5 This latter study was
restricted to prenatally diagnosed cases, though. Prenatally diag
nosed CDHs may be more likely to undergo cytogenetic analysis in
an effort to determine the prognosis for the fetus than would CDH
cases which were diagnosed after birth and expired shortly thereaf
ter. Forty-one percent of CDH cases not known to have a chromo
somal abnormality were found to have other congenital anomalies
not typically associated with the diaphragm defect. The proportion
of CDHs with other anomalies ranged from 28 to 49 percent in
similar studies.’-3
Roughly 24 percent of the CDHs in Hawaii were prenatally
diagnosed, less than half of the proportion observed in Utah.3Since
residents of Hawaii have near universal access to health care, a lower
level of use of prenatal ultrasound in Hawaii is not likely to account
for the discrepancy. CDH is not easily identified on prenatal ultra
sound.9Perhaps those facilities performing prenatal ultrasounds in
Hawaii did not routinely search for the signs of CDH when perform
ing their examinations, or the testmay have been performed early in
the gestation when identifying the defect would have been even
more difficult. The prenatal diagnosis of CDHs demonstrated a
slight increase during the ten-year period of study, so the relatively
poor record of prenatal diagnosis of CDH in Hawaii may be
improving.
Ten percent of all CDH cases in Hawaii (42 percent of prenatally
diagnosed cases) were electively terminated, amuch higher propor
tion than that reported by California (0.8 percent) and Utah (5
percent).23Access to prenatal screens and tests has been found to
vary by geographical area.’°2However, this could only serve as an
explanation for the difference in termination proportions between
Hawaii and Calitbrnia. As noted previously, a greater proportion of
CDHs were prenatally diagnosed in Utah than in Hawaii. More
likely the differences represent variations in attitudes towards and
access to elective terminations between the states. This hypothesis
is possibly supported by the observation that the percentages of
prenatally-diagnosed CDHs which were electively terminated var
ied widely in North America: Utah (10 percent),3 Alabama (21
percent),5United States and Canada (1 percent).7
Maternal race was not found to impact a woman’s risk for having
a pregnancy affected by CDH, a finding which supports that ob
served in California.2 The prevalence of CDH in Metropolitan
Honolulu was similar to that for the rest of the state. While the CDH
rate was roughly the same in three of the four counties in the state
(City and County of Honolulu, Maui County, Kauai County), the
rate in Hawaii County was less than one-fifth that of the others. Also,
women less than age 20 were approximately twice as likely to have
a pregnancy affected by CDH than any other age group. The lack of
statistical significance for this observation precludes offering any
potential explanation for these differences.
Forty-nine percent of the livebirths with CDH in Hawaii between
1987 and 1996 survived to age one year, a rate compatible with that
observed in other states: California (44 percent)2 and Utah (60
percent).3 This is also greater than the 33 percent survival rate
observed in Hawaii during 1975-1982, suggesting that either the
treatment and care ofneonates with CDH has improved between the
two time periods or cases less likely to survive are now being
prenatally diagnosed and electively terminated. A slight decline in
survival rate was identified over the ten-year period studied. This
would appear to contradict the first hypothesis except that this trend
was not statistically significant.
The survival rate has been reported to be lower for CDHs prena
tally diagnosed than those detected after delivery,3something ob
served in the current study where none of the livebirths prenatally
diagnosed with CDH survived, while 58 percent of those detected
after birth survived. Those cases which were prenatally diagnosed
and electively terminated would likely suffer a similar higher risk
for mortality if they had been allowed to continue. This would tend
to support the second hypothesis.
Other studies had found that the survival rate for cases of CDH
with other congenital defects was lower than that for isolated
defects. 13 In the current study, 54 percentof isolated CDHs survived
while 41 percent of those with other defects survived. Thus, if CDHs
with additional congenital defects were more likely to be electively
terminated, then the second hypothesis would be supported. How
ever, the proportions of electively terminated CDHs and total CDHs
with other defects were similar.
Table 2.—Prevalence of congenital diaphragmatic hernia for various
demographic factors, Hawaii, 1987-1 996.
Demographic factor No. Rate’ 95% Cl+
Maternal race/ethnicity
White 18 3.34 1.98-5.27
Far East Asian 9 2.53 1.16-4.81
Pacific islander 12 2.31 1.19-4.04
Filipino 9 2.54 1.16-4.82
County of residence
Honolulu 39 2.52 1.80-3.45
Hawaii 1 0.46 0.01-2.55
Maui 6 3.19 1.17-6.95
Kauai 3 3.15 0.65-9.19
Urbanity
Metro. Honolulu 14 2.49 1.36-4.17
Rest of Hawaii 35 2.56 1.78-3.56
Maternal age (years)
<19 5 6.38 2.07-14.88
20-24 12 2.35 1.22-4.11
25-29 18 3.25 1.93-5.14
30-34 8 1.82 0.79-3.59
35-39 7 3.50 1.41-7.22
>40 1 2.69 0.07-14.98
‘per 10,000 births
+contidence interval
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Most likely both hypotheses contribute to some extent to the
improvement in survival of livebirths with CDH in Hawaii between
1975-1982 and 1987-1996.
The primary limitation with the current study was the small
number of CDH cases included. This limited the statistical power of
the analyses performed and left any differences and trends observed
to be merely suggestive. One way to increase the number of cases,
and thus the statistical power of the analyses, would be to extend the
time period covered. For logistic reasons, the HBDP cannot consis
tently collect data prior to 1986, so future years would be needed for
additional data. Due to the low prevalence of CDH, another analysis
would have to wait for a number of years.
Also, the survival rate for CDH may be overestimated. The HBDP
receives information on all deaths of infants less than age one year
which occur in the state from the DOH. The DOH also receives
information on deaths to state residents which occur in other states,
but it is not known if all out-of-state deaths, particularly among
infants, are reported to the DOH. Thus if an infant with CDH is
transferred to another state for treatment and dies in the other state,
this information may not reach the DOH, and through them the
HBDP. However, this underestimation is believed to below. Due to
the serious nature of the defect, many infants with the defect expire
shortly after delivery. And the critical nature of the condition may
make the time necessary to transport the infant across the Pacific
Ocean unrealistic and treatment of the CDH in Hawaii a preferable
option.
In conclusion, the prevalence of CDH in Hawaii between 1987
and 1996 was found to be slightly lower than that of other popula
tion-based studies performed in other states. With the possible
exception of county of residence and maternal age, demographic
factors did not appear to affect the risk for CDH in the state. A higher
proportion of cases were electively terminated than that observed by
other studies. Prenatal diagnosis of CDH and the presence of
additional congenital defects reduced the chances of survival for an
infant with CDH. For several possible reasons, the survival rate for
CDH has improved over the last two decades.
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